Skip to main content

Published locations for FDA: Increased PAH Risk Seen With Dasatinib

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA: Increased PAH Risk Seen With Dasatinib

User login

  • Reset your password
  • /content/fda-increased-pah-risk-seen-dasatinib
  • /ehospitalistnews/article/40990/pulmonology/fda-increased-pah-risk-seen-dasatinib
  • /internalmedicinenews/article/40990/pulmonology/fda-increased-pah-risk-seen-dasatinib
  • /pulmonary-health-hub/article/40990/pulmonology/fda-increased-pah-risk-seen-dasatinib
  • /oncologypractice/article/40990/pulmonology/fda-increased-pah-risk-seen-dasatinib
  • /hematology-oncology/article/40990/pulmonology/fda-increased-pah-risk-seen-dasatinib
  • /ecardiologynews/article/40990/pulmonology/fda-increased-pah-risk-seen-dasatinib
  • /cardiology/article/40990/pulmonology/fda-increased-pah-risk-seen-dasatinib
  • /internalmedicine/article/40990/pulmonology/fda-increased-pah-risk-seen-dasatinib